News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

PerkinElmer, Inc. (PKI) And Procognia Limited To Offer Breakthrough Protein Array Platform


10/19/2005 5:12:28 PM

MAIDENHEAD, England & BOSTON--(BUSINESS WIRE)--Dec. 15, 2004-- PerkinElmer, Inc. (NYSE: PKI), a global leader in health sciences, and Procognia, a leading developer of innovative and transformational technologies in the field of proteomics, today announced an exclusive distribution and co-marketing agreement to deliver the only complete solution for high-throughput and high-resolution analysis of the glycosylation of proteins. Procognia's U-c fingerprint lectin array-based platform is being combined with PerkinElmer's advanced instrumentation, the Protein Array Workstation(TM) and the recently introduced ProScanArray(TM) HT, to offer the industry's first high-throughput, high-resolution glycoanalysis capability. Certain scientific estimates indicate that more than 60% of critical biological functions involve glycosylated proteins. This new technology will drive significant advancements in the understanding of protein function and structure.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES